Login / Signup

Genotype-guided dual antiplatelet use for TIA and minor stroke by imaging status: a subgroup analysis of the CHANCE-2 trial.

Jing JingXuewei XieS Claiborne JohnstonPhilip M BathZi-Xiao LiXing-Quan ZhaoLiping LiuYilong WangQin XuAnxin WangYong JiangHao LiXia MengYongjun Wangnull null
Published in: Annals of neurology (2022)
Our study demonstrate that imaging evaluation should be emphasized before targeting the best candidates for genotype-guided dual antiplatelet therapy in future clinical research and practice. This article is protected by copyright. All rights reserved.
Keyphrases
  • antiplatelet therapy
  • high resolution
  • acute coronary syndrome
  • percutaneous coronary intervention
  • phase iii
  • atrial fibrillation
  • clinical trial
  • current status
  • drug delivery
  • quality improvement
  • blood brain barrier